We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Allurion Technologies Inc | NYSE:ALUR | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
-0.3112 | -19.95% | 1.2488 | 1.51 | 1.29 | 1.47 | 521,467 | 01:00:00 |
Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced that it will be participating in the Jefferies London Healthcare Conference taking place on November 14-16, 2023 in London. Shantanu Gaur, Allurion’s Chief Executive Officer, and Chris Geberth, Chief Financial Officer, will present on Wednesday, November 15, 2023 at 9:30 a.m. GMT, and will be available for investor 1x1 meetings.
A live webcast of the event will be available on the Allurion website, under Events & Presentations. You can also register for the live webcast here.
About Allurion
Allurion is dedicated to ending obesity. The Allurion Program is a weight-loss platform that combines the Allurion Gastric Balloon, the world’s first and only swallowable, procedure-less gastric balloon for weight loss, the Allurion Virtual Care Suite, including the Allurion Mobile App for consumers, Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale and Health Tracker devices. The Allurion Virtual Care Suite is also available to providers separately from the Allurion Program to help customize, monitor, and manage weight-loss therapy for patients regardless of their treatment plan, whether it is gastric balloon, surgical, medical or nutritional. The Allurion Gastric Balloon is an investigational device in the United States.
For more information about Allurion and the Allurion Virtual Care Suite, please visit www.allurion.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231106883069/en/
US Media Brian Ruby ICR 203-682-8268 brian.ruby@icrinc.com
Global Media Cedric Damour PR Manager +33 7 84 21 02 20 cdamour@allurion.com
Investors Mike Cavanaugh ICR Westwicke 617-877-9641 mike.cavanaugh@westwicke.com
1 Year Allurion Technologies Chart |
1 Month Allurion Technologies Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions